LabCycle, the UK's first circular economy solution for laboratory plastic waste, has secured investment from the Angel Academe EIS Fund, managed by SyndicateRoom. The investment marks the fund's second deal and includes participation from members of the Angel Academe syndicate.
Founded by a team of female scientists, LabCycle addresses plastic waste generated by research and clinical laboratories, which research indicates amounts to an estimated 5.5 million tonnes annually. Historically, this high-grade plastic has been sent to landfill or incinerated due to the complexities of decontamination.
LabCycle's proprietary technology transforms contaminated laboratory plastic waste into high-grade recycled plastic pellets, enabling reuse within the healthcare and biotech industries and supporting a circular economy model.
The funding reinforces the Angel Academe EIS Fund's focus on backing female-founded companies with structural impact and will support LabCycle as it scales its operations and expands adoption across research and healthcare organisations.
It's been hugely encouraging to work with investors who bring genuine conviction, thoughtful challenge and strong support for founders. Angel Academe and SyndicateRoom have backed both the urgency of the problem and the strength of our team, and we're excited to have them alongside us as we scale LabCycle and transform how research and healthcare industries handle plastic waste.
Plastic waste from bio and clinical labs accounts for nearly 1.5% of total global plastic waste. Backing LabCycle is backing a company solving a multi-billion pound logistics and sustainability problem for the entire life sciences industry.
Research and healthcare organisations generate vast volumes of contaminated waste that only LabCycle can recycle, reducing both carbon emissions and cost. Angel Academe are delighted to be a part of the journey, backing a brilliant team and technology.
